Michael David Garrison
CIK 1944816 · EVP & Pres Med.Essntl&BioPharm · last filed 2026-06-11
Michael David Garrison is an EVP & Pres Med.Essntl&BioPharm who has filed 17 SEC Form 4 insider transactions across 2 companies since 2022. The most recent filing shows the insider sold $166.6K of BDX on Jun 11, 2026. Across all open-market trades the lifetime net is −$2.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.1M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.09M
2
17
-$2.75M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BDX | EVP & Pres Med.Essntl&BioPharm | 14,272 | $146.24 | $2.09M | -$2.75M | 15 | 2026-06-11 |
| BECTON DICKINSON & CO (BDXB) Delisted | EVP & President Medical | 6,457 | $48.16 | $311.0K | $0 | 2 | 2023-03-03 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-11 | BDX | Sell (S) | −1,100 | -$166.6K | EDGAR |
| 2026-01-16 | BDX | Mixed | −1,010 | -$334.1K | EDGAR |
| 2025-12-17 | BDX | Sell (S) | −629 | -$123.3K | EDGAR |
| 2025-12-01 | BDX | Mixed | +8,847 | $0 | EDGAR |
| 2025-07-22 | BDX | Mixed | — | -$207.4K | EDGAR |
| 2025-04-10 | BDX | Sell (S) | −479 | -$94.5K | EDGAR |
| 2025-03-04 | BDX | Tax (F) | −178 | $0 | EDGAR |
| 2025-01-21 | BDX | Sell (S) | −597 | -$141.2K | EDGAR |
| 2024-12-20 | BDX | Sell (S) | −2,838 | -$633.8K | EDGAR |
| 2024-11-29 | BDX | Mixed | +3,598 | $0 | EDGAR |